FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment.

Breast Cancer Res Treat 2018 Aug 26;170(3):573-581. Epub 2018 Apr 26.

Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.

Background: Bio-banked formalin-fixed paraffin-embedded (FFPE) tissues provide an excellent opportunity for translational genomic research. Historically matched blood has not always been collected as a source of germline DNA. This project aimed to establish if normal FFPE breast tissue could be used as an alternative to blood.

Methods: Exome sequencing was carried out on matched tumour tissue, normal breast tissue and blood on five patients in the START trial. Retrieved samples had been archived at different centres for at least 13 years. Following tissue macro-dissection and DNA extraction, targeted exome capture was performed using SureSelect Human All Exome v5 reagents (Agilent). Illumina paired-end libraries were prepared from the captured target regions and sequenced on a HiSeq2500 (Illumina) acquiring 2 × 75 bp reads. Somatic variants were called using the MuTect software analysis tool and copy number abnormalities (CNA) were identified using CNVkit. Targeted sequencing and droplet digital PCR were used to validate somatic variants and CNA, respectively.

Results: Overlap of somatic variants and CNA called on tumour versus blood and tumour versus normal breast tissue was good. Agreement in somatic variant calling ranged from 76.9 to 93.6%. Variants with an allele frequency lower than 10% were more difficult to validate irrespective of the type of germline DNA used. Pearson's correlation coefficients for paired comparisons of CNA using blood or normal tissue as reference ranged from 0.70 to 0.94.

Conclusions: There is good correlation between the somatic mutations and CNA called using archived blood or normal breast tissue as germline reference material.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4798-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022520PMC
August 2018
15 Reads

Publication Analysis

Top Keywords

breast tissue
16
normal breast
12
somatic variants
12
tumour versus
8
cna called
8
blood normal
8
germline dna
8
variants cna
8
ffpe breast
8
tissue
7
somatic
5
cna
5
tumour
5
normal
5
blood
5
mutect software
4
targeted sequencing
4
reference material
4
called mutect
4
variants called
4

References

(Supplied by CrossRef)

CM Heaphy et al.
Breast Cancer Res Treat 2009

PS Larson et al.
J Clin Oncol 2005

C Botti et al.
J Am Coll Surg 2000

AK Meeker et al.
Am J Pathol 2004

CM Heaphy et al.
Int J Cancer J 2006

B Xie et al.
Carcinogenesis 2006

S Nik-Zainal et al.
Nature 2016

MHK Troester et al.
Breast Cancer 2016

P Cingolani et al.
Fly (Austin) 2012

E Talevich et al.
PLOS Comput Biol 2014

AB Olshen et al.
Biostatistics 2004

Similar Publications